Committed to exceptional quality
When uncertain data can cause indecision and stall your progression, you need to know that you can act on your results with confidence.
We operate within a controlled, secure and auditable framework designed to deliver robust and reproducible human-relevant evidence. From study design through to data delivery, every aspect is built to maintain consistency, manage risk and protect data integrity.
Standardized processes, experienced scientific oversight and rigorous quality controls help ensure every study generates evidence you can use to support your next development decision.
Certified systems
We operate within ISO-aligned frameworks and GLP and GxP principles, with secure, auditable systems that protect data integrity and support confident, high-stakes decisions.
Reproducibility and risk control
Leveraging a structured approach to study design and execution, we identify risk early and ensure reliable delivery for your complex human tissue studies.
Engineered for precision
Our purpose-built infrastructure and integrated automation deliver high-fidelity data at scale, translating complex biology into a robust and decision-grade evidentiary system.
Make your next decision with confidence
Find out how we replace biological guesswork with clarity, giving your high-potential asset the best chance to reach patients.
Quality systems built to deliver decision-grade impact
Our quality systems are designed to meet the expectations of global pharmaceutical and biotech partners.
- ISO 9001 certified for quality management
- ISO 14001 certified for environmental management
- GLP and GxP-aligned scientific frameworks
- GDPR-compliant data handling
- Cyber Essentials Plus certified
- Regular independent IT and systems audits
These frameworks underpin a controlled, secure and transparent environment for generating decision-grade data.
Proactive, risk-based project planning
At FibroFind, every study is shaped through a rigorous, bespoke planning process grounded in early risk identification.
From resource allocation to compound characteristics and health and safety considerations, any potential challenges your project could face are assessed upfront and addressed through defined mitigation strategies.
This proactive approach maintains control across even the most complex studies, ensuring consistent delivery on time and on budget while preserving the integrity of your data.
Related resources
Poster
Combination of an Acetyl-Coenzyme A Carboxylase Inhibitor and Fibroblast Growth Factor-19 Reduced Tissue Triglyceride Content and Fibrosis in Human Precision-Cut Liver Slices
See how combining ACC inhibition with FGF19 reduced triglyceride accumulation and fibrosis in human precision-cut liver slices.
The evidence your program demands
Speak to our team about your program.